Literature DB >> 19653651

The cytosolic half of helix III forms the substrate exit route during permeation events of the sodium/bile acid cotransporter ASBT.

Naissan Hussainzada1, Tatiana Claro Da Silva, Peter W Swaan.   

Abstract

Site-directed alkylation of consecutively introduced cysteines was employed to probe the solvent-accessible profile of highly conserved transmembrane helix 3 (TM3), spanning residues V127-T149 of the apical sodium-dependent bile acid transporter (ASBT), a key membrane protein involved in cholesterol homeostasis. Sequence alignment of SLC10 family members has previously identified a signature motif (ALGMMPL) localized to TM3 of ASBT with as yet undetermined function. Cysteine mutagenesis of this motif resulted in severe decreases in uptake activity only for mutants M141C and P142C. Additional conservative and nonconservative replacement of P142 suggests its structural and functional importance during the ASBT transport cycle. Significant decreases in transport activity were also observed for three cysteine mutants clustered along the exofacial half of the helix (M129C, T130C, S133C) and five mutants consecutively lining the cytosolic half of TM3 (L145C-T149C). Measurable surface expression was detected for all TM3 mutants. Using physicochemically different alkylating reagents, sites predominantly lining the cytosolic half of the TM3 helix were found to be solvent accessible (i.e., S128C, L143C-T149C). Analysis of substrate kinetics for select TM3 mutants demonstrates significant loss of taurocholic acid affinity for mutants S128C and L145C-T149C. Overall, we conclude (i) the functional and structural importance of P142 during the transport cycle and (ii) the presence of a large hydrophilic cleft region lining the cytosolic half of TM3 that may form portions of the substrate exit route during permeation. Our studies provide unique insight into molecular mechanisms guiding the ASBT transport cycle with respect to substrate binding and translocation events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653651      PMCID: PMC2876721          DOI: 10.1021/bi900616w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  47 in total

1.  Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB.

Authors:  Murray W Huff; Dawn E Telford; Jane Y Edwards; John R Burnett; P Hugh R Barrett; Stephen R Rapp; Nida Napawan; Bradley T Keller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

Review 2.  Structural insights into the mechanism of proton pumping by bacteriorhodopsin.

Authors:  Teruhisa Hirai; Sriram Subramaniam
Journal:  FEBS Lett       Date:  2003-06-12       Impact factor: 4.124

3.  Influence of proline residues in transmembrane helix packing.

Authors:  Mar Orzáez; Jesús Salgado; Ana Giménez-Giner; Enrique Pérez-Payá; Ismael Mingarro
Journal:  J Mol Biol       Date:  2004-01-09       Impact factor: 5.469

4.  Proline residues in transmembrane alpha helices affect the folding of bacteriorhodopsin.

Authors:  H Lu; T Marti; P J Booth
Journal:  J Mol Biol       Date:  2001-04-27       Impact factor: 5.469

5.  Proline-induced distortions of transmembrane helices.

Authors:  Frank S Cordes; Joanne N Bright; Mark S P Sansom
Journal:  J Mol Biol       Date:  2002-11-08       Impact factor: 5.469

6.  Proline residues in two tightly coupled helices of the sulphate transporter, SHST1, are important for sulphate transport.

Authors:  M C Shelden; P Loughlin; M L Tierney; S M Howitt
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

Review 7.  Bile salt transporters: molecular characterization, function, and regulation.

Authors:  Michael Trauner; James L Boyer
Journal:  Physiol Rev       Date:  2003-04       Impact factor: 37.312

8.  1-[4-[4[(4R,5R)-3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]butyl]-4-aza-1-azoniabicyclo[2.2.2]octane methanesulfonate (SC-435), an ileal apical sodium-codependent bile acid transporter inhibitor alters hepatic cholesterol metabolism and lowers plasma low-density lipoprotein-cholesterol concentrations in guinea pigs.

Authors:  Kristy L West; Tripurasundari Ramjiganesh; Suheeta Roy; Bradley T Keller; Maria Luz Fernandez
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

9.  Conformational dynamics of helix S6 from Shaker potassium channel: simulation studies.

Authors:  Joanne N Bright; Indira H Shrivastava; Frank S Cordes; Mark S P Sansom
Journal:  Biopolymers       Date:  2002-09       Impact factor: 2.505

10.  Transport of taurocholate by mutants of negatively charged amino acids, cysteines, and threonines of the rat liver sodium-dependent taurocholate cotransporting polypeptide Ntcp.

Authors:  Daniel Zahner; Uta Eckhardt; Ernst Petzinger
Journal:  Eur J Biochem       Date:  2003-03
View more
  8 in total

Review 1.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

2.  Transmembrane helix 1 contributes to substrate translocation and protein stability of bile acid transporter SLC10A2.

Authors:  Tatiana Claro da Silva; Naissan Hussainzada; Chandra M Khantwal; James E Polli; Peter W Swaan
Journal:  J Biol Chem       Date:  2011-06-06       Impact factor: 5.157

3.  Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2).

Authors:  Richard H Ho; Brenda F Leake; Brad L Urquhart; Jamie C Gregor; Paul A Dawson; Richard B Kim
Journal:  J Gastroenterol Hepatol       Date:  2011-12       Impact factor: 4.029

Review 4.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

5.  Transmembrane domain II of the human bile acid transporter SLC10A2 coordinates sodium translocation.

Authors:  Hairat Sabit; Sairam S Mallajosyula; Alexander D MacKerell; Peter W Swaan
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

6.  Transmembrane domain V plays a stabilizing role in the function of human bile acid transporter SLC10A2.

Authors:  Robyn H Moore; Paresh Chothe; Peter W Swaan
Journal:  Biochemistry       Date:  2013-07-16       Impact factor: 3.162

7.  Mechanistic interpretation of conventional Michaelis-Menten parameters in a transporter system.

Authors:  Diana Vivian; James E Polli
Journal:  Eur J Pharm Sci       Date:  2014-08-27       Impact factor: 4.384

Review 8.  The solute carrier family 10 (SLC10): beyond bile acid transport.

Authors:  Tatiana Claro da Silva; James E Polli; Peter W Swaan
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.